CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $64,979 | -53.0% | 13,234 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $138,396 | +19.3% | 12,886 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $116,000 | +4.5% | 12,379 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $111,000 | -20.7% | 12,209 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $140,000 | +6.9% | 11,561 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $131,000 | -22.5% | 10,785 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $169,000 | +9.0% | 10,907 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $155,000 | -48.2% | 10,846 | -21.3% | 0.00% | -66.7% |
| Q1 2021 | $299,000 | +53.3% | 13,781 | +6.8% | 0.00% | +50.0% |
| Q4 2020 | $195,000 | +14.0% | 12,908 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $171,000 | 0.0% | 13,414 | +34.0% | 0.00% | 0.0% |
| Q2 2020 | $171,000 | – | 10,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |